Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
180 Harvester Dr Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1992 - 1995
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1987 - 1992
- University of Illinois College of MedicineClass of 1989
Certifications & Licensure
- IL State Medical License 1991 - 2020
Publications & Presentations
PubMed
- 23 citationsIndatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a studyKevin R. Kelly, Sikander Ailawadhi, David S. Siegel, Leonard T. Heffner, George Somlo
The Lancet. Haematology. 2021-11-01 - 82 citationsBortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a random...Saad Z. Usmani, Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe
The Lancet. Haematology. 2021-01-01 - 59 citationsIndatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma.Sundar Jagannath, Leonard T. Heffner, Sikander Ailawadhi, Nikhil C. Munshi, Todd M. Zimmerman
Clinical Lymphoma, Myeloma & Leukemia. 2019-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: